David M. Doyle v. DNA SEQ. Inc.

CourtCourt of Chancery of Delaware
DecidedDecember 29, 2025
DocketC.A. No. 2025-0933-SEM
StatusPublished

This text of David M. Doyle v. DNA SEQ. Inc. (David M. Doyle v. DNA SEQ. Inc.) is published on Counsel Stack Legal Research, covering Court of Chancery of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
David M. Doyle v. DNA SEQ. Inc., (Del. Ct. App. 2025).

Opinion

COURT OF CHANCERY OF THE STATE OF DELAWARE SELENA E. MOLINA LEONARD L. WILLIAMS JUSTICE CENTER SENIOR MAGISTRATE IN CHANCERY 500 NORTH KING STREET, SUITE 11400 WILMINGTON, DE 19801-3734

December 29, 2025

Via File & ServeXpress David M. Doyle Joseph E. Brenner, Esquire 71 Beth Lane Gordon Rees Scully Mansukhani, LLP Santa Rosa Beach, FL 32459 221 W. 10th Street, 4th Floor, #447 Wilmington, DE 19801

Re: David M. Doyle v. DNA SEQ. Inc., C.A. No. 2025-0933-SEM

Dear Parties & Counsel:

Through and for the reasons explained in this letter report, the Section 220

claim in this action is dismissed and only the Section 221 claim survives.

This action began in August, through a self-represented litigant’s verified

petition for inspection of books and records and to compel an annual meeting.

Although pleading that prompt court intervention was necessary, through letter, the

self-represented litigant represented that this action was filed to preserve standing

and an expedited schedule was not requested. With that representation, I directed

that this action be placed on the Routine Unassigned Actions docket and stayed until

relief was requested or it was ripe for dismissal under Court of Chancery Rule 41(e).

In October, the corporate defendant, through counsel, filed a motion to

dismiss the Section 220 claim under Court of Chancery Rule 12(b)(6). With relief C.A. No. 2025-0933-SEM December 29, 2025 Page 2 of 9

now requested, I directed that this action be reassigned to me for consideration. On

October 13, I granted the parties’ stipulated briefing schedule while noting: “As the

parties will see in the Guidelines, motion to dismiss briefing is unusual in books and

records proceedings, but, because of [the petitioner’s] placeholder letter, I am

permitting the motion to dismiss and hearing it on a non-expedited track.” Briefing

has now closed, and I do not need oral argument; for the reasons explained herein,

the motion is granted.

I. Background

As noted, this action began with David M. Doyle (the “Petitioner”)’s verified

petition, filed by the Petitioner in a self-represented capacity, on August 19, 2025

(the “Petition”). 1 I accept the well-pled averments in the Petition as true for purposes

of this pleading-stage ruling.

The Petitioner is, and at all relevant times was, a stockholder of DNA SEQ,

Inc. (the “Respondent”), a Delaware corporation. On September 11, 2024, the

Petitioner emailed a written demand for books and records to Andy Nappin, the

Respondent’s Chief Executive Officer. In the cover email to Mr. Nappin, the

Petitioner identified himself as a stockholder of the Respondent, explained that a

demand letter was attached, and noted previous withholding of records and

1 Docket Item (“D.I.”) 1. C.A. No. 2025-0933-SEM December 29, 2025 Page 3 of 9

unsuccessful inquiries. In the demand letter (the “Demand”), the Petitioner

demanded that the Respondent’s board of directors “take immediate action to

address serious concerns regarding governance, financial transparency, and potential

breaches of fiduciary duty.” 2 The Petitioner further demanded that six categories of

records be produced within 15 days.3

In the Demand, the Petitioner explained that his purposes for inspection were

to (1) investigate potential mismanagement or breaches of fiduciary duty, (2) value

his interests, (3) communicate with other stockholders regarding governance, (4) and

determine the suitability of current management, As to (1), he explained the

Respondent’s “persistent failure to hold annual shareholder meetings or to make

required disclosures raises legitimate governance and compliance concerns.” To that

2 D.I. 3 Ex. 2. 3 Namely: (1) board minutes and resolutions relating to the transition of the secretary/treasurer position and regarding the company’s reorganization efforts; (2) stockholder meeting records explaining the lack of annual stockholder meetings and records of any decisions in lieu of such meetings; (3) financial information, specifically annual and quarterly financial statements for the past three fiscal years, detailed information on the Respondent’s current financing structure, and comprehensive records regarding the disposition of the Petitioner’s holdings; (4) stockholder meeting minutes for the last three years; (5) strategic reports and presentations provided to the board regarding strategic decisions or corporate performance; and (6) any records, including emails between directors, relating to suspected breaches of fiduciary duty, officer/director self- dealing, transfer of corporate assets into subsidiaries, failure to conduct annual shareholder meetings, and the self-election of directions without notice or vote. Id. C.A. No. 2025-0933-SEM December 29, 2025 Page 4 of 9

end, the Petitioner also demanded that the Respondent’s board schedule a

stockholders’ meeting within 45 days.

When his 15-day deadline was not met, the Petitioner emailed the

Respondent’s directors. 4 After first congratulating them on the Respondent being

named “AI Drug Discovery Company of the Year 2024 by Life Sciences Review”

he asked for a response to the Demand. Specifically, the Petitioner wrote that, absent

a response by October 10, 2024, he would consider legal remedies.

The Respondent thereafter engaged with the Petitioner on the Demand. On

October 1, 2024, the Respondent proposed a confidentiality order to govern any

production. The parties then went back and forth on drafts through December 2024

but could not agree on the necessary restrictions or carve outs. Then, in February

2025, the Respondent indicated it would no longer engage with the Petitioner. After

the Respondent did not respond to the Petitioner’s last email attempt (in August

2025), the Petitioner filed this action.5

4 D.I. 3 Ex. 2 at 5–6. 5 This factual recitation addresses the well-pled facts in the Petition. The Petitioner has made several filings purporting to amend the Petition. On August 27, the Petitioner attempted to add an exhibit 8 to the Petition by letter submission. D.I. 10–12. Then, on September 11, the Petitioner tried to add, again by letter, an exhibit 9. D.I. 13–15. These filings were before the Respondent moved to dismiss. Then, after the Motion was fully briefed, on November 24, the Petitioner filed a letter identifying a related case pending before Vice Chancellor Laster—C.A. No. 2025-1206-JTL—and attempted to expand the record in this action by cross-referencing records in that action. D.I. 31–32. C.A. No. 2025-0933-SEM December 29, 2025 Page 5 of 9

As I noted, this action was initially stayed, at the Petitioner’s request. That

stay was lifted, and this action was assigned to me when the Respondent moved to

dismiss the Section 220 claim (the “Motion”). 6 The Motion was fully briefed on

November 13, 2025.7 After the Respondent’s reply brief, and despite agreeing to a

typical three-brief schedule, on November 14, the Petitioner filed a cover letter

attaching what he represented was “a new, properly sworn Section 220 demand and

supporting documentation.” 8 The Petitioner explained he was submitting it to “cure

the technical defect” identified in the Motion.

II. Analysis

As I noted when approving the parties’ proposed briefing schedule, pleading-

stage motions are generally disfavored by this Court in summary proceedings. But,

for this action, I approved the parties’ stipulation to brief the Motion, acknowledging

the Petitioner’s placeholder letter.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Clinton v. Enterprise Rent-A-Car Co.
977 A.2d 892 (Supreme Court of Delaware, 2009)
Savor, Inc. v. FMR Corp.
812 A.2d 894 (Supreme Court of Delaware, 2002)

Cite This Page — Counsel Stack

Bluebook (online)
David M. Doyle v. DNA SEQ. Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/david-m-doyle-v-dna-seq-inc-delch-2025.